Combined effect of an ACE inhibitor, perindopril, and interferon on liver fibrosis markers in patients with chronic hepatitis C

被引：0
|
作者：
Hitoshi Yoshiji
Ryuichi Noguchi
Hiroshi Fukui
机构：
[1] Nara Medical University,Third Department of Internal Medicine
来源：
Journal of Gastroenterology | 2005年 / 40卷
关键词：
Public Health; Hepatitis; Internal Medicine; Interferon; Combine Effect;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：215 / 216
页数：1
相关论文
共 50 条
  • [41] Assessment of Eight Non-Invasive Markers of Liver Fibrosis in Egyptian Patients With Chronic Hepatitis C
    Atta, Mohamed Magdi E.
    El Sharkawy, Entesar H.
    Said, Ebada
    El Feky, Halo M.
    El Toukhy, Naglaa
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S457 - S457
  • [42] Non-invasive markers of fibrosis in chronic hepatitis C patients
    Dobreanu, Minodora
    Enache, Liviu S.
    Enache, Elena L.
    [J]. REVISTA ROMANA DE MEDICINA DE LABORATOR, 2009, 14 (01): : 7 - 17
  • [43] Liver stiffness measurement in patients with chronic hepatitis B is not as useful as that in patients with chronic hepatitis C for the assessment of liver fibrosis
    Seo, Yeon Seok
    Kim, Eun Sun
    Kwon, Yong Dae
    Park, Sanghun
    Keum, Bora
    Park, Beom Jin
    Kim, Yong Sik
    Jeen, Yoon Tae
    Chun, Hoon Jai
    Kim, Chang Duck
    Ryu, Ho Sang
    Um, Soon Ho
    [J]. HEPATOLOGY, 2007, 46 (04) : 842A - 842A
  • [44] What is the real effect of interferon alfa on hepatitis C virus replication and quasispecies and the liver in patients with chronic hepatitis C?
    Pawlotsky, JM
    Bouvier, M
    Bastie, A
    Lefrere, JJ
    DaCosta, I
    Germanidis, G
    Pellerin, M
    Zafrani, ES
    Dhumeaux, D
    [J]. HEPATOLOGY, 1997, 26 (04) : 955 - 955
  • [45] Daclatasvir and asunaprevir treatment improves liver function parameters and reduces liver fibrosis markers in chronic hepatitis C patients
    Miyaki, Eisuke
    Imamura, Michio
    Hiraga, Nobuhiko
    Murakami, Eisuke
    Kawaoka, Tomokazu
    Tsuge, Masataka
    Hiramatsu, Akira
    Kawakami, Yoshiiku
    Aikata, Hiroshi
    Hayes, C. Nelson
    Chayama, Kazuaki
    [J]. HEPATOLOGY RESEARCH, 2016, 46 (08) : 758 - 764
  • [46] Discordance between biochemical markers of liver activity and fibrosis (Actitest®-Fibrotest®) and liver biopsy in patients with chronic hepatitis C
    Fontanges, T.
    Bailly, F.
    Trepo, E.
    Chevallier, M.
    Maynard-Muet, M.
    Nalet, B.
    Beorchia, S.
    Pillon, D.
    Moindrot, H.
    Froissart, B.
    Slaoui, M.
    Tinel, X.
    Pradat, P.
    Trepo, C.
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2008, 32 (10): : 858 - 865
  • [47] Enhanced Liver Fibrosis (ELF) Panel as a Predictor of Liver Fibrosis in Chronic Hepatitis C Patients
    Fernandes, Flavia F.
    Dellavance, Alessandra
    Andrade, Luis Eduardo C.
    Campos, Frederico F.
    Pereira, Gustavo
    Terra, Carlos
    Pereira, Joao Luiz
    Figueiredo, Fatima A.
    Perez, Renata M.
    Ferraz, Maria Lucia G.
    [J]. HEPATOLOGY, 2013, 58 : 923A - 923A
  • [48] The relationship between serum fibrosis markers and fibrosis in liver tissue in patients with chronic viral hepatitis
    Candevir, A.
    Aksu, H. S. Z.
    Kurtaran, B.
    Inal, A. S.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S336 - S336
  • [49] Noninvasive indirect serum markers of liver fibrosis in patients with chronic viral hepatitis
    Afyon, Murat
    Artuk, Cumhur
    [J]. TURKISH JOURNAL OF GASTROENTEROLOGY, 2016, 27 (04): : 397 - 398
  • [50] Chronic hepatitis C and liver fibrosis, the significance of oxidative stress and implications of interferon treatment
    Serejo, FS
    Filipe, P
    Fernandes, A
    Costa, A
    Ramalho, F
    Moura, MC
    [J]. JOURNAL OF HEPATOLOGY, 2001, 34 : 80 - 81
12345